United States · 
What does Mid Atlantic Bio Angels invest in?
Mid Atlantic Bio Angels invests most often at Seed and Series B (67% of the rounds on record), in sectors such as Life Science.
Mid Atlantic Bio Angels highlights
- 01
3 rounds on record
- 02
Mostly Seed and Series B: 67% of its rounds
- 03
Sole investor in 1 rounds, median $3.0M
What they do
The Mid Atlantic Bio Angels (BioAngels™) group, is an angel investor group focused exclusively on new and emerging life science companies.From their own website
- Type
- Angel network (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- Life Science
- Based in
- New York, United States
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first3 appearances
- 2023
1 round
- Aug
- 2013
2 rounds
- Oct
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
7 of 24 we have independently watched raise
DeeplifeEvrysbioFeeltherapeuticsHealionicsOpsidioSenecatherapeuticsSinglepassAstrocytepharmaAuctussurgicalBMI OrganBankBusiness IT EssentialsCerusendoCookiedatabaseCouragegrowthpartnersCsearchgroupEisneramperFemselectHexembHilltopbioNewviewsurgNewyorkbioSanaShapesensingSonorousnv
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.